Sharechat Logo

Senior Trust Retirement Village Listed Fund (NZX: SRF)

Wednesday 27th January 2021

Text too small?

Further to the announcement made by Senior Trust Retirement Village Listed Fund on Tuesday, 26 January 2021, NZX Operations (“NZXO”) advises that SRF will be delisting from the NZX Main Board (NZSX).

The final day of trading in SRF will be Monday, 1 February 2021, with SRF units being halted and suspended at close of business that day. SRF units will cease to be quoted from close of business on Wednesday, 3 February 2021.

SRF will be delisted as an NZX issuer within seven business days after its units cease quotation. NZXO will provide this date to market in a second memorandum once it is finalised.

Please contact NZX Product Operations on +64 4 496 2853 or with any queries.

Please see the link below for more details:

Senior Trust Retirement Village Listed Fund (SRF) Delisting

Source: Senior Trust Retirement Village Listed Fund

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

27th October 2021 Morning Report
The a2 Milk Company Limited (NZX: ATM) Investor Day 2021
Contact Energy Limited (NZX: CEN) Considers Green Capital Bond Offer
Tourism Holdings Limited (NZX: THL) Sells Mighway and SHAREaCAMPER to Camplify
26th October 2021 Morning Report
Harmoney Corp Limited (NZX: HMY) Prices $105m Inaugural ABS Transaction
New Zealand Rural Land Company Limited (NZX: NZL) Agreement to acquire large scale dairy asset portfolio
EROAD Limited (NZX: ERD) launches Clarity Solo Dashcam
22nd October 2021 Morning Report
Pictor ready to roll out game-changing COVID antibody test in New Zealand